|Client||Access TCA (USA)|
Novartis in the spotlight at AHA 2015 thanks to the beMatrix solutions
Access TCA was tasked with creating an eye catching, engaging, brand experience for the premier of Novartis' breakthrough new heart failure drug: Entresto.
“Our design was meant to be a 3 dimensional embodiment of the Entresto brand itself. In addition to the premier of this new therapy at AHA 2015 there was also a disease state component to the exhibit aimed at further educating healthcare professionals on the risk factors associated with heart disease.”